BMRN — BioMarin PharmaceuticalFREE
Price
$55.02
previous close
Median target
$84
across current calls
Implied return
+52.7%
median target vs. price
Coverage
25 analysts · 35 calls
current predictions
Consensus
26/9/0+26 net
Buy / Hold / Sell
Current analyst calls on BMRN
Sorted by implied return. Each row is one analyst's live rating and price target.
| Analyst | Score | Rank | Succ% | Ret% | Firm | Call | Target | Impl. return | Updated |
|---|---|---|---|---|---|---|---|---|---|
| Cory Kasimov | – | – | – | Evercore ISI Group | Buy | $120 | +118.1% | May 21, 2026 | |
| Cory Kasimov | – | – | – | Evercore ISI Group | Buy | $120 | +118.1% | May 5, 2026 | |
| Phil Nadeau | – | – | – | TD Cowen | Buy | $120 | +118.1% | Aug 6, 2024 | |
| Phil Nadeau | – | – | – | TD Cowen | Buy | $120 | +118.1% | May 21, 2026 | |
| Whitney Ijem | – | – | – | Canaccord Genuity | Buy | $116 | +110.8% | May 7, 2026 | |
| Whitney Ijem | – | – | – | Canaccord Genuity | Buy | $111 | +101.7% | May 22, 2026 | |
| Eliana Merle | – | – | – | Barclays | Buy | $105 | +90.8% | May 21, 2026 | |
| Ilya Zubkov | – | – | – | Freedom Capital Markets | Buy | $105 | +90.8% | Mar 2, 2026 | |
| Akash Tewari | – | – | – | Jefferies | Buy | $104 | +89.0% | May 21, 2026 | |
| Joon Lee | – | – | – | Truist Securities | Buy | $100 | +81.8% | Dec 23, 2025 | |
| Alexandria Hammond | – | – | – | Wolfe Research | Buy | $95 | +72.7% | Jul 15, 2025 | |
| Yun Zhong | – | – | – | Wedbush | Buy | $94 | +70.9% | May 21, 2026 | |
| Michelle Gilson | – | – | – | Canaccord Genuity | Buy | $91 | +65.4% | Mar 1, 2021 | |
| Olivia Brayer | – | – | – | Cantor Fitzgerald | Buy | $90 | +63.6% | Feb 20, 2025 | |
| Debjit Chattopadhyay | – | – | – | Guggenheim | Buy | $86 | +56.3% | Feb 25, 2026 | |
| Olivia Brayer | – | – | – | Cantor Fitzgerald | Buy | $85 | +54.5% | Mar 2, 2026 | |
| Allison Bratzel | – | – | – | Piper Sandler | Buy | $84 | +52.7% | Feb 6, 2026 | |
| Allison Bratzel | – | – | – | Piper Sandler | Buy | $82 | +49.0% | May 21, 2026 | |
| William Pickering | – | – | – | Bernstein | Buy | $82 | +49.0% | May 5, 2026 | |
| Eric Joseph | – | – | – | J.P. Morgan | Buy | $80 | +45.4% | May 19, 2026 | |
| George Farmer | – | – | – | Scotiabank | Hold | $80 | +45.4% | Aug 5, 2025 | |
| George Farmer | – | – | – | Scotiabank | Hold | $80 | +45.4% | Feb 20, 2025 | |
| Jason Gerberry | – | – | – | B of A Securities | Buy | $80 | +45.4% | May 20, 2026 | |
| Jason Zemansky | – | – | – | B of A Securities | Buy | $80 | +45.4% | May 19, 2026 | |
| Mohit Bansal | – | – | – | Wells Fargo | Buy | $75 | +36.3% | Feb 18, 2026 | |
| Mohit Bansal | – | – | – | Wells Fargo | Buy | $75 | +36.3% | May 21, 2026 | |
| Salveen Richter | – | – | – | Goldman Sachs | Hold | $69 | +25.4% | May 11, 2026 | |
| Paul Matteis | – | – | – | Stifel | Hold | $68 | +23.6% | May 21, 2026 | |
| Luca Issi | – | – | – | RBC Capital | Hold | $66 | +20.0% | May 5, 2026 | |
| Joseph Schwartz | – | – | – | Leerink Partners | Hold | $62 | +12.7% | May 18, 2026 | |
| Joseph Schwartz | – | – | – | Leerink Partners | Hold | $60 | +9.0% | Dec 3, 2025 | |
| Mitchell Kapoor | – | – | – | HC Wainwright & Co. | Hold | $50 | -9.1% | May 18, 2026 | |
| Mitchell Kapoor | – | – | – | HC Wainwright & Co. | Hold | $50 | -9.1% | May 22, 2026 | |
| Jessica Fye | – | – | – | J.P. Morgan | Buy | – | – | Oct 27, 2025 | |
| Joon Lee | – | – | – | Truist Securities | Buy | – | – | Mar 3, 2026 |
Analyst track records are Premium — unlock every analyst's score, rank and success rate.
Implied return = price target ÷ yesterday's close − 1: the move the stock would make if the analyst's target were hit. These are forward-looking predictions, not realized returns. Only reliable-basis calls are included; the consensus figures above are computed from the calls in this table.